MME
Metallomembrane endopeptidase, also known as membrane metalloendopeptidase. MME is also called CALLA (Common Acute Lymphocytic Leukemia antigen) a cell surface marker for the most common form of acute lymphocytic leukemia. There is however some confusion regarding the specificity of this marker. MME is identical to neutral endopeptidase and is the target of antibodies directed against podocytes- cells which line the glomerulus or primary filtration site in the kidney. Mutations in the gene for MME that shorten it can cause a kidney disease called membranous nephropathy. The gene for MME is on chromosome 3 in the region 3q21-q27. MME is also synonymous with CD10, membrane metalloendopeptidase, enkephalinase, and neprilysin.
Read Also:
- MMR
Measles, mumps, rubella vaccine, a combination vaccine.
- MMWR
The Morbidity and Mortality Weekly Report, a weekly scientific publication prepared and published by the CDC (US Centers for Disease Control and Prevention). MMWR contains data and reports on specific health and safety topics. The data are on specific diseases as reported by state and territorial health departments. The reports are on infectious and chronic […]
- Modafinil
An oral drug first approved by the FDA in 1998 for the treatment of narcolepsy, a condition in which there is an uncontrollable desire to sleep. Modafinil promotes wakefulness. In 2004 the FDA also approved modafinil for the treatment of obstructive sleep apnea and sleeping problems caused by shift work. Modafinil is said to be […]
- Modifiers, biological response (BRMs)
Substances that stimulate the body’s response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts for use in treating cancer, rheumatoid arthritis, and other diseases. BMRs used in biological therapy include monoclonal antibodies interferon, interleukin-2 (IL-2), and several types […]
- MODY
Maturity onset diabetes of the young.